CN105233088A - Medicine for treating chronic pelvic inflammatory disease - Google Patents

Medicine for treating chronic pelvic inflammatory disease Download PDF

Info

Publication number
CN105233088A
CN105233088A CN201510791933.1A CN201510791933A CN105233088A CN 105233088 A CN105233088 A CN 105233088A CN 201510791933 A CN201510791933 A CN 201510791933A CN 105233088 A CN105233088 A CN 105233088A
Authority
CN
China
Prior art keywords
parts
effects
medicine
inflammatory disease
pelvic inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510791933.1A
Other languages
Chinese (zh)
Inventor
包莉丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510791933.1A priority Critical patent/CN105233088A/en
Publication of CN105233088A publication Critical patent/CN105233088A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine for treating a chronic pelvic inflammatory disease. The medicine is prepared from the following medicinal raw materials in parts by weight: 10 parts of angelica sinensis, 6 parts of ligusticum wallichii, 5 parts of radix paeoniae rubra, 8 parts of salviae miltiorrhizae, 4 parts of coix seeds, 3 parts of dahurian patrinia herb, 4 parts of peach kernels and 3 parts of Chinese violet. According to the medicine, angelica sinensis has the effects of nourishing blood and promoting blood circulation; ligusticum wallichii has the effects of promoting circulation of blood and qi; radix paeoniae rubra has the effects of clearing heat and cooling blood; salviae miltiorrhizae has the effects of promoting blood and qi circulation and removing stasis; coix seeds have the effects of strengthening spleen, excreting dampness, clearing heat and eliminating pus; dahurian patrinia herb has the effects of draining pus, dissolving carbuncle, promoting blood circulation to remove stasis; peach kernels have the effects of activating blood to remove stasis; and Chinese violet has the effects of clearing heat to remove stasis, cooling blood and diminishing swelling. The medicinal materials are combined to achieve the effects of promoting blood circulation to remove stasis, consolidating constitution, reinforcing vital essence, dispelling dampness and resolving toxins, and can be used for effectively treating the chronic pelvic inflammatory disease. Clinical experiments prove that the medicine can be used for treating the chronic pelvic inflammatory disease safely and effectively.

Description

A kind of medicine being used for the treatment of chronic pelvic inflammatory disease
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of medicine being used for the treatment of chronic pelvic inflammatory disease.
Background technology
Chronic pelvic inflammatory disease often fails thoroughly to treat for acute pelvic inflammatory disease, or caused by the poor course of disease delay of body, but also can die of illness without acute pelvic inflammatory disease.Its main pathology changes into connective tissue proliferation and adhesion, can show as chronic defeated ovum inflammation and hydrosalpinx, adnexitis and tubo-ovarian cyst and chronic pelvic paramitritis.
How not obvious clinical general manifestation is, and low grade fever, susceptible sometimes can be had tired, and course of disease elder can occur neurasthenia symptom.Topical manifestations is mainly lower abdomen falling inflation, pain and lumbosacral aching pain, increases the weight of after fatigue of being everlasting, sexual intercourse and before and after menstruation; Also menorrhagia, menoxenia, the symptom such as infertile can be had.Chang Chenghou position, gynecologial examination uterus, limitation of activity or adhesion are fixed.
Current doctor trained in Western medicine clinical treatment chronic pelvic inflammatory disease is based on antibacterials expectant treatment, but for a long time or repeatedly the multiple antibacterial drug therapy of conbined usage there is no significant curative effect sometimes, and exist medication lack of standardization, easily cause fastbacteria and produce and the various disadvantages such as double infection.Physiotherapy is as ultrashort wave, laser medicine ion-transmission etc.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide a kind of medicine being used for the treatment of chronic pelvic inflammatory disease, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing chronic pelvic inflammatory disease.
In order to achieve the above object, the present invention is by the following technical solutions:
Be used for the treatment of a medicine for chronic pelvic inflammatory disease, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 6 parts, Radix Paeoniae Rubra 5 parts, Radix Salviae Miltiorrhizae 8 parts, Semen Coicis 4 parts, Herba Patriniae 3 parts, 4 parts, Semen Persicae, Herba Violae 3 parts.
Inventor thinks, damp and hot congestion is retarded by silt, the cold and deficiency of CHONG and REN meridians causes blood room just to open, and vessels of the uterus is hollow.So cause chronic pelvic inflammatory disease.Therefore, should detoxify based on blood circulation promoting and blood stasis dispelling, vital base and primordial QI consolidating, damp eliminating when adopting Chinese traditional treatment.
The present invention uses: Chinese angelica blood supplementing is invigorated blood circulation; Rhizoma Chuanxiong blood-activating and qi-promoting; Radix Paeoniae Rubra clearing away heat and cooling blood; The blood stasis dispelling of Radix Salviae Miltiorrhizae blood-activating and qi-promoting; Row is dense for Semen Coicis spleen invigorating eliminating dampness by diuresis, heat clearing away; The evacuation of pus of Herba Patriniae eliminating carbuncle, blood circulation promoting competent silt; Semen Persicae blood circulation promoting and blood stasis dispelling; Herba Violae heat-clearing and toxic substances removing, removing heat from blood is subsided a swelling.All medicines share, and play effect of blood circulation promoting and blood stasis dispelling, vital base and primordial QI consolidating, damp eliminating removing toxic substances altogether, effectively treat chronic pelvic inflammatory disease.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects undergoing chronic pelvic inflammation 80 example for 2012 altogether between year December of December ~ 2014, all from Out-patient Clinic of Department of Gynecology, be women, 25 ~ 50 years old age, the married 75 example, unmarried 5 example.The course of disease 5 months ~ 5 years.
Diagnostic criteria: adopt gynaecological examination to combine with B ultrasonic:
(1) ultrasound diagnosis: uterus rectum is recessed hydrops, attachment area is visited and sausage shape dark space or irregular dark space or abnormal echo;
(2) uterus tenderness; Side or bilateral adnexa thicken or increase thick;
(3) leucorrhea amount is many, presents purulence or yellow;
(4) there is official jargon operation history, have pelvic inflammatory disease medical history;
(5) lumbosacral aching pain, lower abdomen falling pain, and in menstruation, sexual intercourse or tired postemphasis.
Above 5 have more than 3 can determine diagnosis.
Meet above-mentioned diagnostic criteria, the women that the age is greater than 18 years old.
Exclusion standard: trimester of pregnancy, women breast-feeding their children; Merge serious cardiopulmonary hepatorenal disease person and malignant tumor person.
2, test method
The decoct that the oral the present invention of all patients obtains according to embodiment 1, every day 3 times.12 weeks courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Judge according to " diagnosis of chronic pelvic inflammatory disease disease and efficacy assessment standard ".
1. cure: B ultrasonic prompting pelvic cavity image is normal, gynecologial examination attachment area without thickening, tenderness and enclosed mass, clinical symptom disappearance;
2. take a turn for the better: B ultrasonic prompting pelvic hydrops reduces, and gynecologial examination attachment area thickens, tenderness and enclosed mass phenomenon alleviate, clinical symptoms partial disappearance;
3. invalid: sign and symptom are obtained for comparatively significantly to be improved.Recovery from illness: the symptom such as abdominal pain and distension, menoxenia disappears completely, and the visible chronic pelvic inflammatory disease of row color ultrasound examination disappears substantially.
3.2 therapeutic outcome
80 routine patients cure 55 examples, and take a turn for the better 21 examples, invalid 4 examples, total effective rate 95%.There is laxativeness in treatments period 1 example, has no other obvious adverse reaction.It is safe and effective that visible the present invention is used for the treatment of chronic pelvic inflammatory disease, has the value applied.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Radix Angelicae Sinensis 10 grams, Rhizoma Chuanxiong 6 grams, Radix Paeoniae Rubra 5 grams, Radix Salviae Miltiorrhizae 8 grams, Semen Coicis 4 grams, Herba Patriniae 3 grams, 4 grams, Semen Persicae, Herba Violae 3 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of chronic pelvic inflammatory disease.Oral, every bu morning, noon and afternoon take for three times.
Embodiment 2
Take: Radix Angelicae Sinensis 10 grams, Rhizoma Chuanxiong 6 grams, Radix Paeoniae Rubra 5 grams, Radix Salviae Miltiorrhizae 8 grams, Semen Coicis 4 grams, Herba Patriniae 3 grams, 4 grams, Semen Persicae, Herba Violae 3 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of chronic pelvic inflammatory disease.Oral, daily once.
Embodiment 3
Take: Radix Angelicae Sinensis 10 grams, Rhizoma Chuanxiong 6 grams, Radix Paeoniae Rubra 5 grams, Radix Salviae Miltiorrhizae 8 grams, Semen Coicis 4 grams, Herba Patriniae 3 grams, 4 grams, Semen Persicae, Herba Violae 3 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of chronic pelvic inflammatory disease.Oral, every bu is taken for twice sooner or later.

Claims (4)

1. one kind is used for the treatment of the medicine of chronic pelvic inflammatory disease, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 6 parts, Radix Paeoniae Rubra 5 parts, Radix Salviae Miltiorrhizae 8 parts, Semen Coicis 4 parts, Herba Patriniae 3 parts, 4 parts, Semen Persicae, Herba Violae 3 parts.
2. be used for the treatment of the medicine of chronic pelvic inflammatory disease as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 6 parts, Radix Paeoniae Rubra 5 parts, Radix Salviae Miltiorrhizae 8 parts, Semen Coicis 4 parts, Herba Patriniae 3 parts, 4 parts, Semen Persicae, Herba Violae 3 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. be used for the treatment of the medicine of chronic pelvic inflammatory disease as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 6 parts, Radix Paeoniae Rubra 5 parts, Radix Salviae Miltiorrhizae 8 parts, Semen Coicis 4 parts, Herba Patriniae 3 parts, 4 parts, Semen Persicae, Herba Violae 3 parts; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weight portion.
4. be used for the treatment of the medicine of chronic pelvic inflammatory disease as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 6 parts, Radix Paeoniae Rubra 5 parts, Radix Salviae Miltiorrhizae 8 parts, Semen Coicis 4 parts, Herba Patriniae 3 parts, 4 parts, Semen Persicae, Herba Violae 3 parts; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, obtains capsule; Above-mentioned part all refers to weight portion.
CN201510791933.1A 2015-11-17 2015-11-17 Medicine for treating chronic pelvic inflammatory disease Pending CN105233088A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510791933.1A CN105233088A (en) 2015-11-17 2015-11-17 Medicine for treating chronic pelvic inflammatory disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510791933.1A CN105233088A (en) 2015-11-17 2015-11-17 Medicine for treating chronic pelvic inflammatory disease

Publications (1)

Publication Number Publication Date
CN105233088A true CN105233088A (en) 2016-01-13

Family

ID=55031081

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510791933.1A Pending CN105233088A (en) 2015-11-17 2015-11-17 Medicine for treating chronic pelvic inflammatory disease

Country Status (1)

Country Link
CN (1) CN105233088A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108114237A (en) * 2017-12-31 2018-06-05 赵再绒 A kind of Chinese medicinal formulae for treating chronic pelvic inflammatory disease and preparation method thereof
CN110496198A (en) * 2018-05-19 2019-11-26 陕西天地人和药业有限公司 A kind of oral drugs for treating chronic pelvic inflammatory disease

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1237451A (en) * 1999-04-01 1999-12-08 魏秀珍 Enema liquor for woman pelvic inflammation
CN102430025A (en) * 2011-12-01 2012-05-02 吉林大学 Medicine composition for treating pelvic inflammation and preparation method thereof
CN103027968A (en) * 2011-10-07 2013-04-10 雷蕾 Preparation method of medicinal preparation for preventing and treating chronic pelvic inflammation
CN104840884A (en) * 2015-05-22 2015-08-19 郭立新 Traditional Chinese medicinal preparation for treating chronic pelvic inflammatory disease

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1237451A (en) * 1999-04-01 1999-12-08 魏秀珍 Enema liquor for woman pelvic inflammation
CN103027968A (en) * 2011-10-07 2013-04-10 雷蕾 Preparation method of medicinal preparation for preventing and treating chronic pelvic inflammation
CN102430025A (en) * 2011-12-01 2012-05-02 吉林大学 Medicine composition for treating pelvic inflammation and preparation method thereof
CN104840884A (en) * 2015-05-22 2015-08-19 郭立新 Traditional Chinese medicinal preparation for treating chronic pelvic inflammatory disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
朱时珍 等: "中西医结合治疗慢性盆腔炎60例疗效观察", 《济宁医学院学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108114237A (en) * 2017-12-31 2018-06-05 赵再绒 A kind of Chinese medicinal formulae for treating chronic pelvic inflammatory disease and preparation method thereof
CN110496198A (en) * 2018-05-19 2019-11-26 陕西天地人和药业有限公司 A kind of oral drugs for treating chronic pelvic inflammatory disease

Similar Documents

Publication Publication Date Title
CN102688410B (en) Chinese medicinal composition for treating chronic pelvic inflammation
CN103768531B (en) Chinese medicine composition being used for the treatment of rheumatoid arthritis and preparation method thereof
CN105233088A (en) Medicine for treating chronic pelvic inflammatory disease
CN105497237A (en) Traditional Chinese medicine used for treating hemorroide
CN102988846A (en) Chinese materia medica preparation for curing pelvic congestion syndrome
CN104997907A (en) Medicine for curing haemorrhoids
CN103893480A (en) Traditional Chinese medicine preparation for treating kidney deficiency and blood stasis type oviduct obstructive infertility
CN104435362B (en) A kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease
CN102631633B (en) Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis
CN103550620B (en) A kind of externally-applied medicinal composition treating rheumatalgia
CN102784376B (en) Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis
CN104784619A (en) Traditional Chinese medicine for treating post-traumatic early limb swelling
CN104306898A (en) Orally taken traditional Chinese medicine for treating hysteromyoma
CN102697865B (en) Long pepper Chinese herba preparation for curing headache and preparation method
CN103610906A (en) Pharmaceutical composition for treating pain from rheumatism
CN104740423A (en) Traditional Chinese medicine for treating rheumatoid arthritis
CN103330843B (en) Medicinal liquor for treating postpartum rheumatism
CN103860782A (en) Pharmaceutical composition for treating chronic pelvic inflammation
CN117771316A (en) Traditional Chinese medicine composition for moxa sticks
CN105288483A (en) Drug for treatment of endometritis
CN103239695A (en) Preparation method of traditional Chinese medicine for treating alcohol-related acute glomerulonephritis
CN108310332A (en) A kind of Chinese medicine preparation and preparation method thereof for treating hemiplegia caused by apoplexy
CN110025683A (en) A kind of drug for treating rheumatoid arthritis
CN105148214A (en) Drug for treating uterine fibroids
CN110025682A (en) A kind of drug for treating rheumatoid arthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160113